“China cancer society cancer support treatment committee 2018 academic annual conference” was held in Namzningz, China, from November 23 through 24, 2018.

During this conference, Yuzo Endo, MD, Ph.D. (Department of Tumor Pathology, Hamamatsu School of Medicine, Japan), gave a presentation titled “Evidence-based biological response modifier supporting for anti-cancer treatment”, and introduced BioBran. This presentation was very informative, and attracted several hundred participants.